<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01935713</url>
  </required_header>
  <id_info>
    <org_study_id>EZ Study</org_study_id>
    <nct_id>NCT01935713</nct_id>
  </id_info>
  <brief_title>Preliminary Investigation of Novel Methods to Reduce Children's Secondhand Smoke Exposure</brief_title>
  <acronym>EZI</acronym>
  <official_title>Novel Methods to Reduce Children's Secondhand Smoke Exposure I</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Oklahoma</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Oklahoma</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The overall aim of the current study is to determine if the use of nicotine containing
      products by caregivers who smoke and who are not interested in quitting, is effective in
      reducing children's secondhand smoke exposure.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2012</start_date>
  <completion_date type="Actual">December 2012</completion_date>
  <primary_completion_date type="Actual">December 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in child salivary cotinine</measure>
    <time_frame>2, 4, 8, and 12 weeks</time_frame>
    <description>Child salivary cotinine will be measured to assess the level of secondhand smoke exposure. We will measure the change throughout the study.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Parent and Child Lung Function</measure>
    <time_frame>2, 4, 8, and 12 weeks</time_frame>
    <description>We will collect both parent and child spirometry data and compare changes.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">89</enrollment>
  <condition>Secondhand Smoke</condition>
  <arm_group>
    <arm_group_label>Electronic Cigarette</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants received the electronic cigarette for use instead of cigarettes when in the presence of their child(ren) for up to 8 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dissolvable Tobacco Lozenge</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants received the dissolvable tobacco lozenge for use instead of cigarettes when in the presence of their child(ren) for up to 8 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dissolvable Nicotine Lozenge (Nicorette)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants received the dissolvable nicotine lozenge (Nicorette) for use instead of cigarettes when in the presence of their child(ren) for up to 8 weeks.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Nicotine polacrilex</intervention_name>
    <description>Participants were given the choice of 2mg or 4mg lozenges depending on how many cigarettes per day they reported to smoke.</description>
    <arm_group_label>Dissolvable Nicotine Lozenge (Nicorette)</arm_group_label>
    <other_name>Nicorette</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Electronic Cigarette</intervention_name>
    <description>Participants were given an e-cigarette starter kit, charging case, and cartridges in either 12mg or 16 mg nicotine, depending on their current amount of cigarettes smoked per day.</description>
    <arm_group_label>Electronic Cigarette</arm_group_label>
    <other_name>Smoke Tip</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dissolvable Tobacco Lozenge</intervention_name>
    <description>Participants were given Ariva (light to moderate smokers) or Stonewall (heavier smokers, &gt;2 packs per day).</description>
    <arm_group_label>Dissolvable Tobacco Lozenge</arm_group_label>
    <other_name>Ariva, Stonewall</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria: In order to be included in the study, participants must:

          1. be the primary caregiver(defined as a person who spends the most time with the child
             and spends a minimum of 4 hours per day in the presence of the child) of a child
             between the ages of 3-11 (if caregiver has more &gt; 1 child between 3-11 years, we will
             include the youngest)

          2. smoke at least 10 cigarettes per day for the past year

          3. indicate that they smoke around their child or in the car or home at least one time
             per week]

          4. have no intention of quitting smoking in the next 12-weeks

          5. aged 18-65 years

          6. be fluent in English

          7. have no recent history of cardiovascular distress that may contraindicate medicinal
             nicotine lozenge use (heart attack in the past year, arrhythmia, uncontrolled
             hypertension)

          8. not currently pregnant, planning to become pregnant, or breastfeeding

          9. do not use non-cigarette tobacco (cigars, chewing tobacco)

         10. have no prior use of any potential reduced exposure product

         11. have no major psychiatric impairment, including psychosis, suicidality, and/or any
             current alcohol/drug abuse or dependence

        Exclusion Criteria:

          -  Does not meet all of the requirements of inclusion criteria
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Theodore Wagener, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>OTRC, OU Children's Hospital Dept. of Pediatrics, OU Cancer Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The Children's Hospital at OU Medical Center</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 30, 2013</study_first_submitted>
  <study_first_submitted_qc>August 30, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 5, 2013</study_first_posted>
  <last_update_submitted>May 3, 2017</last_update_submitted>
  <last_update_submitted_qc>May 3, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 4, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nicotine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

